Clinical trial · Observational
A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer
NCT06343181CI-TRIAL-00075620unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Qualitative observational study with the aim to explore medication adherence in a sample of patients with metastatic breast cancer. Patients with metastatic breast cancer receiving or having received oral oncologic therapy, and attending the Division of Medical Senology at the European Institute of Oncology, will be included and enrolled in this research project."
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Metastatic Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Metastatic breast cancer (BC)
- description
- Patients with diagnosis of BC
Primary outcomes (1)
- measure
- Evaluation of factors influencing patients' adherence to medical therapy
- timeFrame
- 1 month
- description
- Collection of data in order to evaluation of factors influencing patient's adherence to medical treatment
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age over 18 years old; * Diagnosis of metastatic breast cancer; * Availability of an internet connection and a PC or Tablet (for remote focus groups); * Signing of the informed consent. Exclusion Criteria: * Presence of psychiatric or neurological conditions impairing the ability to comprehend the questions in Focus Groups or to express free consent to participate in the study; * Presence of medical or oncological conditions other than metastatic breast cancer; * Refusal to sign the informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.